The new RUMA Companion Animal and Equine Group will initially focus on encouraging efforts to promote responsible antibiotic use.
Steve Howard, head of clinical services at the People’s Dispensary for Sick Animals and secretary general of the new group, said: "RUMA has spearheaded successful efforts to steward antibiotic use in farmed animals over the past five years, and we would like to see whether its principles can augment the considerable progress that’s already been made in the companion animal and equine sectors.
"The most notable of RUMA’s initiatives is the Targets Task Force, which has seen leading vets and farmers from each species working together with industry groups to develop meaningful goals for reducing, refining or replacing antibiotic use.
"Through establishing such proactive approaches towards antibiotic stewardship in companion animals and equines, we hope to optimise their health and welfare – as well as that of humans and the environment."
RUMA says that although total antibiotic sales are significantly lower for companion animals compared with the farming sector, even relatively low use can result in resistance to key medicines if good stewardship principles are not applied.
The collaboration will cover use of medicines in dogs, cats, rabbits, small mammals, exotic animals kept as pets, and equids. The aim is for the UK to lead the way in these sectors through evidence-based and measurable activities that will promote and enhance stewardship.
Gwyn Jones, chair of the new group (pictured right), said: "As a collaborative group we need to establish evidence-based protocols for reducing, replacing or refining antibiotic use in companion animals, to further help preserve and prolong the use of these vital tools for human and animal health.
“Efforts will be focused towards identifiable goals so that progress can be monitored and demonstrated. But we will also promote practical, practice-level resources, guidance and measures aimed at driving positive behaviour changes and protecting patients and practitioners alike."
Research conducted by the PDSA in 2017 found that 75% of dogs had received a primary vaccination course when young, which dropped to 72% in 2019. According to the BSAVA, it's the first time that vaccination rates have seen a sustained drop over a three year period since vaccinations were first introduced to the UK in the '60s.
The project, titled 'A mixed methods approach to quantifying and characterising vaccine uptake and vaccine hesitancy in UK companion animals' will combine quantitative analysis of existing data from electronic health records with qualitative approaches. It will include interviews and focus-group discussions with vets and owners to gain an in-depth understanding of patterns of uptake of vaccination in UK.
Experiences, perceptions and behaviours around uptake of vaccination and the rise of vaccine hesitancy in UK pet owners will also be investigated.
Dr Gina Pinchbeck, project leader at the University of Liverpool said: “Vaccination is a vital component of preventive healthcare and it is well acknowledged that sub-optimal vaccination uptake may be associated with re-emergence of vaccine-preventable diseases in populations.
“It is essential that we understand the reasons for vaccine hesitancy in the pet population so that we can use the best methods to promote vaccine acceptance and uptake and this will be the primary focus of the study.”
The study will include the development of a knowledge and dissemination strategy, in association with PetSavers and BSAVA. This will include a project website, publication of scientific research and other articles for both practicing veterinary surgeons and for pet-owners, press releases, conference presentations and public-engagement presentations.
BSAVA President Professor Ian Ramsey added: “This project will be of great value to the veterinary profession and continues the co-operation between BSAVA and the University of Liverpool to build on the successes of the original SAVSNET partnership.”
For information on how to apply for the PhD, contact Dr Gina Pinchbeck (ginap@liverpool.ac.uk).
Reference
Running from 14th-23rd July, the interactive webinars will be delivered in 5 half-day sessions, led by UK pet food consultants, scientists, and vets.
The course includes:
Sarah Hormozi, PFMA Head of Science & Education, said: "With some of the most credible industry experts as our speakers, this is a rare opportunity for pet professionals across the UK and EU to improve and refresh their knowledge of animal nutrition, pet food legislation, marketing regulations and manufacturing methods, from the comfort of their own home or office!”
For the full programme, list of speakers, registration details and prices, visit www.pfma.org.uk/pfma-training-webinar-series.
The charity is asking everyone to donate £5 and nominate 5 friends to get involved in the activities.
The activities are:
For more information, visit: https://www.vetlife.org.uk
Vetlife Helpline is available 24 hours a day, 365 days a year on: 0303 040 2551 or via anonymous email at https://helpline.vetlife.org.uk
The BVA says that securing 'Great Workplaces' will be a collaborative assessment process.
Each workplace will have a dedicated, experienced accreditor from a veterinary background, who will work with leadership teams and employees to gather a full picture of their workplace.
Workplaces will be assessed in four main areas: health and wellbeing, leadership and management, culture, and learning and development.
Successful workplaces will achieve either gold or silver accreditation.
Those that don’t meet the criteria yet will be recognised as ‘working towards’ accreditation and will be supported to make the changes needed to achieve success next time around.
Successful workplaces will hold their accreditation for three years and at the end of that period they will be required to undergo reassessment to retain their accredited status.
BVA President Anna Judson said: “As well as attracting more people to join our veterinary profession, ensuring we retain the incredible talent we already have is critical to building a resilient and sustainable veterinary workforce.
"Positive workplace culture is central to achieving this and Great Workplaces by BVA is an innovative new approach that puts the well-being of vet teams front and centre.
"The knock-on impact will be good for vets and vet practices, good for clients and ultimately, good for animal welfare.
Photo: BVA
“Workplaces accredited under this new scheme, will be seen as employers of choice, attracting top talent who seek fulfilling careers and a healthy work-life balance.
"For existing team members, working in a recognised Great Workplace could enhance job satisfaction.”
A number of workplaces have already undertaken Great Workplaces accreditation during a series of pilots in 2023.
Two, Westport Veterinary Clinic in Linlithgow and South Moors in Devon, have become the first veterinary workplaces to receive a silver accreditation.
Fiona Leathers at Westport Veterinary Clinic, said: "At Westport Veterinary Clinic, our collaboration with the British Veterinary Association and its Great Workplaces accreditation scheme has been transformative.
"It has given us invaluable insights into how this initiative positively impacts workplace culture and employee well-being.
“The simplicity of the accreditation process and the approachable nature of BVA’s accreditors facilitated seamless integration of the scheme’s principles into our daily routines.
"The tangible impact of the Great Workplaces accreditation has been profound.
"It's fostered a more inclusive, supportive, and cohesive environment, elevating employee satisfaction and bolstering team morale significantly.
"This experience extends beyond personal growth; it solidifies our belief in cultivating healthy work cultures.”
www.bva.co.uk/great-workplaces
The event will deliver more than 130 hours of CPD, including a programme of five simultaneous live streams each day. Delegates will also have opportunities to network and socialise - with peers, colleagues and experts in chat rooms and breakout sessions, and with industry partners - such as event sponsor Hill’s Pet Nutrition - in the online exhibition hall.
Live content will be delivered via 24 content modules and a library of 100 on-demand webinars will support the 80 hours of live programming. Scientific content will be available on the platform for 30 days and then available to attendees via the BSAVA library.
For the first time nursing, clinical and business topics will be blended into modules from which delegates can select the content they need.
Professor Ian Ramsey, President of the BSAVA, said: "On the clinical side, we’re covering everything from chronic pain and neurology to cardiology and orthopaedics – whatever your interests, there will be something for you."
“Most sessions in the live programme will feature two speakers, each delivering short presentations followed by a live, audience-led conversation. This new approach means delegates can explore the multi-faceted disciplines of the small animal veterinary world and see the clinical challenges from different points of view and, most importantly, join in.
“Pre-recorded webinars support the live programme, enabling delegates to dip in at their leisure. We’ve also swapped traditional lengthy notes or MCQs, with practical resources such as client handouts or flowcharts for delegates to take back to their clinics”.
Congress will also be covering an update on sustainability issues through the module titled, ‘can the profession go green?’ On the practical business front, recruitment and retention will be discussed and keynote speaker Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader.
BSAVA Congress prices start at £99 +VAT. To register, visit www.bsavaevents.com
Krka says Milprazon Chewable is the first wormer in its category with proven palatability for dogs based on EMA Testing Guidelines.
In a study¹, more than 85% of dogs ate the tablet ‘voluntarily’, with 75% taking it unprompted from their food bowl.
Milprazon chewable is available in a range of presentations suitable for puppies from two weeks old (0.5kg) and kittens from six weeks old.
Milprazon comes in colour-coded packaging for easier dispensing.
Will Ridgway, Krka’s National Sales Manager said: "Milprazon Chewable is a premium product.
"It offers pet owners the reliability of Milbemycin oxime and Praziquantel, together with enhanced palatability, while supporting practice profitability."
The weekly sessions will offer practical guidance for veterinary surgeons and nurses about how they can manage chronic cases in line with guidelines issued by the Royal College of Veterinary Surgeons, the British Veterinary Association and the government.
Dechra’s Veterinary Technical Advisor Emily Casey BVM&S MRCVS will present the first webinar tackling Addison’s disease on Thursday April 2 from 1pm to 2pm and again from 7pm to 8pm. It will be available to watch again or download via the Dechra Academy.
It will include advice on how to stabilise patients and administer Zycortal while respecting government guidelines, including prioritisation of blood testing, use of telemedicine and provision of additional owner support. Each webinar represents one hour of CPD.
Dechra’s Technical Services Manager Jamie Walker said: “Since the outbreak of coronavirus began, we have received a large number of calls from practices wanting advice and guidance on how they should be managing chronic cases at this time.
"Our case management webinars will offer practical advice on a number of common small animal issues and aim to provide reassurance and support to veterinary professionals at this challenging time."
Further webinars will be held each Wednesday in April.
To register for the free webinars visit www.dechra.co.uk/events.
Ear cropping in UK dogs was exposed by BBC’s Panorama as a growing problem particularly with extreme mix breeds such as American Bullies and XL Bullies.
Dave said: “We need to urgently relook at legislation in the UK to prevent the serious rise in ear cropping which we’ve witnessed in recent years.”
It is currently illegal for a dog’s ears to be cropped in the UK, and proposals for a ban on importing dogs with cropped ears have been put forward by the Government. However, Dave says this legislation doesn’t go far enough to prevent an exponential rise in dogs with cropped ears, which some owners see as a status symbol: “At the moment the legislation in the UK is very hard to enforce unless you actually catch someone in the act of cropping the dog’s ears.
“It’s not currently illegal for someone to own a dog with cropped ears.
"So, if an owner were challenged by enforcement agencies, they’d just say ‘I bought the dog like this’ and there’s no liability.” “We propose that any dogs who already have cropped ears at the time the ban is due to come into force, must be registered on a database, which enforcement agencies and the veterinary profession would have access to.
"And for anyone owning an unregistered dog with cropped ears after the legislation comes into effect, then it’s a criminal offence.”
The Panorama programme also exposed co-ownership – where the breeder and the pet owner share ownership of the dog, often the bitch – as a system which has enabled unscrupulous breeders to get around current laws on dog breeding in the UK.
The breeder retains ownership of the stud dog and uses the network of co-owned female dogs for reproduction purposes. Dave said: “People need to be made aware of the risks of entering into a legal contract as a co-owner of one of these extreme mix breed dogs. “All the contracts I have seen in my role as an expert witness are strongly weighed in favour of the breeder. “So for example if the bitch does not have the requisite number of litters, or becomes ill or injured and has to be put to sleep, then the co-owner is fully liable for the full purchase cost of the dog to the breeder. “Considering that the female dogs are often valued in excess of £12k and the breeder may well have connections to organised crime or have a criminal record, there are huge risks for people entering into co-ownership.”
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
Apparently, there were over 100 times more recorded outbreaks of equine flu across the UK in 2019 than the year before1, and numerous equestrian events were cancelled as a result.
The company says that despite this, as of 2019, only about half of all UK horses are vaccinated2.
Blaise Scott-Morris MRCVS, Equine Marketing and Technical Manager at MSD Animal Health said: "Last year’s outbreaks of equine flu rocked the equine world, raising important animal welfare issues and costing the racing industry millions.
"Furthermore, they highlighted the need for good preventative healthcare and, in particular, vaccination. It’s vital that more owners are encouraged to vaccinate and those that already have, to keep up with their annual vaccinations and health checks so we don’t experience the same suffering again."
MSD's campaign invites horse owners to join the movement to #fightequineflu, and there is a range of materials to help practices promote the campaign and encourage clients to talk about vaccination and preventative healthcare, including an educational infographic poster, a social media pack and new resources on the Chameleon appointment reminder system.
MSD will itself be promoting the campaign on social media (Facebook: @Keeping Britains Horses Healthy, Instagram: @KeepingHorsesHealthy), and through partnerships with consumer channels such as Horse and Country TV.
There is also a new information resource online at www.kbhh.co.uk/achoo, which offers horse owners links to a range of other educational preventative health materials and horse care advice.
To request your Fight Equine Flu practice pack, speak to your MSD account manager.
References
According to the company, coprophagia affects 23% of dogs, with 16% being repeat offenders.
Copro-nil is a powder which, when added to food, makes the resultant faeces unpalatable. This, says the company, breaks the coprophagia habit and gives the owner an opportunity to implement training to eradicate the behaviour long-term.
Copro-nil has been relaunched in smaller 100g pots with a new look designed to make the product more appealing.
The product comes with advice about behavioural training methods to help owners understand how they can break the coprophagia habit in the long term.
Will Peel, product manager at TVM UK said: "The new format and packaging have been designed to help deal with this very unpleasant problem which many owners believe is a behaviour that dogs will grow out of.
"The new format is intended to demonstrate that Copro-nil, combined with effective behavioural training, can help resolve the problem effectively.’
Copro-nil also provides a comprehensive B vitamin source as deficiencies in B vitamins may contribute to coprophagia.
Downloadable advice sheets for veterinary staff to share help and advice with clients are available from www.tvm-uk.com/coprophagia.
BVA’s advice comes as the four nations of the UK launch contact tracing programmes to move from blanket lockdown restrictions to a more targeted approach, in line with strategies to ease lockdown restrictions.
Although slightly different across the UK, each programme will ask those who test positive for coronavirus to identify people they have been in recent contact with and those people will be contacted and asked to self-isolate for 14 days.
Relevant contact appears to be spending more than 15 minutes within two metres of another person or being in direct face-to-face contact (less than one metre) with them. At present, the schemes are voluntary, but may become mandatory at a later stage.
Northern Ireland: Test, trace, isolate, supportEngland: NHS Test and TraceScotland: Test and ProtectWales: Test Trace Protect
Employees in self-isolation are entitled to Statutory Sick Pay for every day they are in isolation, as long as they meet the eligibility conditions. Further roll out of testing may enable people to return to work sooner that 14 days if they receive a negative test.
BVA President Daniella Dos Santos said: "The next step in the Covid-19 response is shifting to a more targeted approach, but it’s clear that this could have a very significant impact on individual veterinary practices if a member of the team tests positive. The nature of veterinary work means we are in close contact with our colleagues in order to work safely with animals.
“Many veterinary teams will be understandably anxious about the impact on their ability to staff a full rota to maintain 24/7 care. And there are significant concerns about the impact on animal health and welfare if practices are unable to provide veterinary services.
"Our advice is to continue working in fixed pairs or small teams as much as possible to reduce your contact with different individuals and continue to practise good hygiene and biosecurity.
"We continue to ask neighbouring practices to work together to support those impacted by self-isolation and ensure full geographical cover for veterinary services.
"We recognise some veterinary professionals will be worried, but we urge everyone to comply with the contact tracing programmes."
Lax-a-Past is a palatable paste that can be administered orally to kittens and cats aged over 6 months.
It can be used weekly to help stop hairballs from forming or in higher doses over a consecutive three-day period to help eliminate them.
Carol Morgan, Brand Manager from Dechra Veterinary Products (pictured right) said: “Hairballs are a well-known issue for cats. Lax-a-Past is a complementary feed that offers a simple, easy-to-administer solution to help relieve the digestion problems caused by hairballs.
“It is very easy for owners to administer as the required dosage can be squeezed out and spread on a front paw or given directly into the mouth."
Lax-a-Past is available in a 70g tube.
For more information visit www.dechra.co.uk.
The new Chestergates ophthalmology service will offer a wide range of treatments for eye conditions, including: cryotherapy, corrective lid surgery, rhytidectomy, nasal fold ablation, cherry eye and scrolled cartilage, keratotomy, keratectomy, pedicle conjunctival graft, corneo-conjunctival transposition, bioimplants for corneal reconstruction, glaucoma diagnosis and monitoring, management of dry eye (KCS) and neurological dry eye, retro-bulbar disease investigation and treatment, cataract assessment, and intracapsular lens extraction.
The service will be led by Chestergates Advanced Practitioner in Ophthalmology, Endika Garcia MRCVS DVM PGCertSAOphthal.
Endika graduated in 2016 from the University of Valencia, completed a rotating internship, then worked for a few years in different hospitals in Spain, before moving to the UK, enrolling on the BSAVA Certificate in Small Animal Ophthalmology and being awarded Advanced Practitioner status.
Endika will be supported by a 25 strong specialist nursing team, four nurse students, one lab technician, two sterile technicians and a team of receptionists and support colleagues.
Consultations and surgical procedures will be offered at Chestergates Veterinary Specialists on Mondays and Thursdays between 8am and 5pm.
https://chestergates.org.uk/referral-services
This year, there are 3 RVN seats and 2 Student seats available.
The RVN candidates for three available seats are: Kimberley Boparai, Felicity Caldwell, Victoria Foulkes, Declan Jones, Krishna Mistry and Cheryl Plimmer
The Student candidates for two available seats are: Kate Davies, Julia Hamilton, Poppy Meredith and Ell Stokes
BVNA President, Charlotte Pace said: “It takes courage and dedication to run for BVNA Council, and the lucky candidates will be shaping the direction of veterinary nursing.
"Now is when our members have the chance to vote for the people that they think will represent their voice best on BVNA Council for the next 3 years.
"I would urge everyone to read the manifestos, engage with the social media content throughout the election period, and vote.”
www.bvna.org.uk/blog/bvna-council-elections-2023--candidates-announced
The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing.
It has a two-year shelf life and a broached shelf life of six months.
Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner.
"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”
https://www.dechra.co.uk/cushings-connect
https://www.dechra.co.uk/addisons-connect
https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole
https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534
A few examples of the products in J.A.K Marketing's 'ThinkGreen' portfolio include the Purfect Anaesorber, BAG’EMS biodegradable poop bags, Tick Twister products (made from recycled plastic) and Bamboo stick cotton buds.
The website also gives a snapshot of the sorts of things that J.A.K itself does to reduce its impact on the environment, including the use of environmentally-friendly brown paper and recycled cardboard boxes for packaging. The company has also switched to certified sustainable FSC paper for most of its printed marketing materials (including the master catalogue) and is working with courier companies who have targets in reducing CO2 emissions.
Managing Director, John Holland said: "J.A.K Marketing is committed to the protection and preservation of the world’s ecosystem. By undertaking our productivity and operations responsibly and sustainably, we recognise that reducing the environmental impact of our activities is very important. We will strive to achieve environmental excellence within the veterinary industry and will continue to work closely with our employees and commercial partners to establish and follow the principles of our ThinkGreen policy."
Sales Director, James Johnson said: "With growing interest towards the protection of the environment, we need to make it easier for veterinary practices to identify products where there is a benefit to the environment by simply switching to a like for like ‘greener’ alternative. As part of our long-term strategy, we are dedicated to growing this area of our business, welcoming feedback from the profession of how we can all work together to achieve this."
Those wanting to offer inspiration and feedback can do so on the form at the bottom of the ‘ThinkGreen’ page: www.jakmarketing.co.uk/thinkgreen.
The company says its new design is modular, allowing veterinary practices to customise kennels to their requirements now, and then upgrade them and add components as their needs change over time.
Options include dimmable daylight lighting or Casco Pet’s DRC Lighting System with three modes: Daylight (white), Recovery (red), and Cleaning (blue UVA), built-in thermostatically controlled heat mats, an illuminated glass whiteboard for easy recording and viewing of patient notes, integrated IV stand and pump holders, an internal ceiling vent and ventilation kit and an integrated plug socket and USB port .
Matthew Bubear, CEO, Casco Pet, said: “Our new generation of WellKennels, which have been designed to meet the dynamic demands of modern veterinary practices, allow practitioners to elevate the care they provide today while ensuring sustained adaptability for the needs of tomorrow."
WellKennels are certified by the International Society of Feline Medicine and are part of FearFree’s Preferred Product Program, the global initiative dedicated to preventing and alleviating fear, anxiety and stress in pets.
The new WellKennels will be unveiled at the London Vet Show, ExCel London, 16-17 November, on Stand H35.
https://cascopet.com/uk/products-and-services/veterinary
Mars says that during a typical anaesthetic procedure, less than five percent of the volatile anaesthetic agent delivered to a patient is absorbed and metabolised and about 95% is exhaled.
SageTech’s gas-capture technology – which is currently used in human healthcare – works by capturing the waste anaesthetic agent exhaled during an operation by adsorbing it into a reusable capture canister.
These waste anaesthetic agents can then be extracted from the filter, without incinerating or release them into the atmosphere.
Ellie West, RCVS and EBVS® European Specialist in Veterinary Anaesthesia and Analgesia, and Linnaeus Environmental Sustainability Lead, said: “As a leading provider of veterinary care, we have a responsibility to take climate action at scale and lead the way toward more sustainable practices.
“Our innovative collaboration should help us take a significant step forward in our sustainability journey, aimed at contributing to a better future for the planet – and the people and pets who depend on it.”
The one-year pilot will start with 10 Linnaeus primary care and referral veterinary practices in the UK, after which Mars says it plans to explore the potential application of this technology across other parts of its business.
https://www.sagetechveterinary.com
Willows says it is currently the only centre in the UK to offer the procedure, and one of very few in the world.
Simon Swift, an RCVS and European specialist in small animal cardiology (pictured right), heads the cardiology team at Willows.
He said: “Transcatheter edge-to-edge mitral valve repair (TEER) is already considered an alternative to surgical repair in human patients and there have been some very promising early clinical results in dogs.
“The procedure is performed under general anaesthesia through a small incision in the chest wall.
“Access within the beating heart is achieved by a needle puncture at the apex of the heart which is highlighted by continuous X-ray images and an ultrasound of the heart via a probe placed in the oesophagus.
“This allows correct positioning of a V-clamp across the mitral valve to reduce the amount of leakage.
“It’s a procedure that delivers meaningful results and an improved quality of life and, because it’s a minimally invasive process, patients are typically discharged from hospital within two days.”
www.willows.uk.net
This, say the authors, could lead to shorter hospitalisation time and less stress for donor cats.
For the study, researchers at the Royal Veterinary College measured the systolic blood pressure of 100 client-owned cats which had been randomly assigned to receive IVFT or no fluid after blood donation.
Owners were also contacted following donation to record any changes in their cat.
The results showed no significant difference in blood pressure between cats that received post-donation IVFT and those that didn't.
The main reported changes were minor bruising at the venepuncture site and mild lethargy, with no significant difference between the IVFT and no-IVFT groups.
These findings suggest that IVFT post-blood donation may not be necessary, as haemodynamic stability appears to be maintained despite the loss of blood.
Dr Guedra Allais, lead author of the study, said: "Our study showed no significant difference in blood pressure at different time points in feline donors that received intravenous fluid compared to others that didn’t receive any fluid.
"Other perfusion parameters such as capillary refill time, heart rate and pulse quality were not evaluated, and we recommend considering intravenous fluid in any feline donors if any major changes are detected on post donation physical examination.”
The authors say that study seeks to redress the lack of evidence-based information that has so far been published on the epidemiology and clinical management of non-neoplastic anal sac disorders (ASD).
The study, which was carried out within the RVC’s VetCompass programme, focused especially on identifying breeds with increased or reduced risk of anal sac disorders.
The breeds at greatest risk of an anal sac disorder compared with crossbreeds included Cavalier King Charles spaniel, King Charles spaniel and Cockapoo.
Conversely, breeds at reduced risk included larger breed dogs including Boxer, German Shepherd Dog and Lurcher. Flat-faced (brachycephalic) breeds such as Shih Tzu had 2.6 times the risk for anal sac disorders compared to long-skulled breeds such as Border Collies. Spaniel-types, Dachshund-types and Poodle also showed increased risk for anal sac disease.
The study identified 2,372 anal sac disorder cases from a population of 104,212 dogs attending VetCompass participating practices during 2013.
Other findings included:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: “During two decades in first opinion practice, anal sac problems in dogs were a routine daily presentation for me. However, when I searched the literature to find evidence on the best way to treat these dogs or even on which breeds were at most risk, there was almost no information available. It seemed back then that only problems that were severe enough to be referred to universities in large numbers were researched.
"As a result, vets in first opinion practice generally had to work out for themselves what seemed to be the best treatment in these cases. It is refreshing now to see research on common problems in dogs under first opinion veterinary care being reported. Owners and vets needs this evidence vitally.”
Anette Loeffler, Associate Professor of Veterinary Dermatology at the RVC and co-author of the paper, said: "This study shines a spotlight on critically important area of veterinary practice: antibiotic usage. Twenty percent of dogs presenting with an anal sac disorder received antibiotics even though diagnostic criteria for anal sac infection or proof of efficacy of antibiotic treatment are lacking.
"At a time when antimicrobial resistance presents one of the biggest threats to human and animal health, this highlights an urgent need for further study of these disorders in order to improve dog welfare but also to help vets in making responsible antibiotic treatment decisions in the interest of public health.”
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
The new suite offers chemotherapy and radiotherapy treatment facilities under one roof, including a linear accelerator (LINAC) which enables treatment of tumours previously considered untreatable.
Southfields has two full-time client-facing specialists in radiation oncology and two on-site, full-time double-boarded medical and radiation oncologists, along with dedicated radiotherapy technicians and therapeutic radiographers.
RCVS and European Specialist Sarah Mason, Southfield's lead in general oncology, said: “Southfields is already renowned as being the leader in cancer treatment for small animals in the UK and the opening of our dedicated oncology and radiotherapy suite takes patient care to an even higher level.”
www.southfields.co.uk